Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FRANSSEN, C. F. M.
Right arrow Articles by TERVAERT, J. W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FRANSSEN, C. F. M.
Right arrow Articles by TERVAERT, J. W. C.
J Am Soc Nephrol 10:1506-1515, 1999
© 1999 American Society of Nephrology


REGULAR ARTICLES

In Vitro Neutrophil Activation by Antibodies to Proteinase 3 and Myeloperoxidase from Patients with Crescentic Glomerulonephritis

CASPER F. M. FRANSSEN*,{dagger}, MINKE G. HUITEMA{dagger}, ANNEKE C. MULLER KOBOLD{dagger}, WIA W. OOST-KORT{dagger}, PIETER C. LIMBURG{dagger}, ANTON TIEBOSCH{ddagger}, COEN A. STEGEMAN*, CEES G. M. KALLENBERG{dagger} and JAN W. COHEN TERVAERT*,{dagger}

* Division of Nephrology, Department of Internal Medicine, University Hospital Groningen, Groningen, The Netherlands.
{dagger} Division of Clinical Immunology, Department of Internal Medicine, University Hospital Groningen, Groningen, The Netherlands.
{ddagger} Department of Pathology, University Hospital Groningen, Groningen, The Netherlands.

Correspondence to Dr. Casper F. M. Franssen, Department of Internal Medicine, Division of Nephrology, University Hospital Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. Phone: 31 50 3612621; Fax: 31 50 3619310; E-mail: m.j.s.graler{at}int.azg.nl

Abstract. Previously, it was found that patients with necrotizing crescentic glomerulonephritis (NCGN) and anti-neutrophil cytoplasmic autoantibodies (ANCA) directed against proteinase 3 (anti-PR3) had a faster deterioration of renal function and more active renal vasculitic lesions than patients with ANCA directed against myeloperoxidase (anti-MPO). Because ANCA-mediated neutrophil activation is thought to play an important role in the pathophysiology of this form of glomerulonephritis, this study was conducted to determine whether anti-PR3 are capable of inducing a more pronounced activation of neutrophils in vitro than anti-MPO. To test this hypothesis, the release of reactive oxygen radicals, as assessed by ferricytochrome c reduction and by dihydrorhodamine 123 oxidation, and the release of granule constituents from healthy donor neutrophils upon stimulation with IgG fractions were measured from 17 anti-PR3- and 14 anti-MPO-positive patients with active NCGN. Patients with anti-PR3 had a higher renal activity index (P < 0.05) compared with patients with anti-MPO. IgG fractions from anti-PR3-positive patients induced more oxygen radical release from tumor necrosis factor-{alpha}-primed neutrophils compared with IgG fractions from anti-MPO-positive patients, as assessed by ferricytochrome c reduction (P < 0.05) and dihydrorhodamine 123 oxidation (P < 0.01). In addition, IgG fractions from anti-PR3-positive patients generated more neutrophil degranulation of ß-glucuronidase (P < 0.01) than IgG fractions from anti-MPO-positive patients. In conclusion, IgG fractions from anti-PR3-positive patients with NCGN are more potent activators of the respiratory burst and degranulation in vitro than IgG fractions from anti-MPO-positive patients. These observations may be relevant in view of the clinical differences between anti-PR3- and anti-MPO-positive patients with NCGN.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. M. Uriarte, K. R. McLeish, and R. A. Ward
Anti-proteinase 3 antibodies both stimulate and prime human neutrophils
Nephrol. Dial. Transplant., October 24, 2008; (2008) gfn580v1.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
D. Huugen, J. W. Cohen Tervaert, and P. Heeringa
TNF-{alpha} Bioactivity-Inhibiting Therapy in ANCA-Associated Vasculitis: Clinical and Experimental Considerations
Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(5): 1100 - 1107.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. Huugen, H. Xiao, A. van Esch, R. J. Falk, C. J. Peutz-Kootstra, W. A. Buurman, J. W. C. Tervaert, J. C. Jennette, and P. Heeringa
Aggravation of Anti-Myeloperoxidase Antibody-Induced Glomerulonephritis by Bacterial Lipopolysaccharide: Role of Tumor Necrosis Factor-{alpha}
Am. J. Pathol., July 1, 2005; 167(1): 47 - 58.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Schreiber, B. Otto, X. Ju, M. Zenke, U. Goebel, F. C. Luft, and R. Kettritz
Membrane Proteinase 3 Expression in Patients with Wegener's Granulomatosis and in Human Hematopoietic Stem Cell-Derived Neutrophils
J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2216 - 2224.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. J. Yang, W. F. Pendergraft, D. A. Alcorta, P. H. Nachman, S. L. Hogan, R. P. Thomas, P. Sullivan, J. C. Jennette, R. J. Falk, and G. A. Preston
Circumvention of Normal Constraints on Granule Protein Gene Expression in Peripheral Blood Neutrophils and Monocytes of Patients with Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis
J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2103 - 2114.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. A. Rarok, P. C. Limburg, and C. G. M. Kallenberg
Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies
J. Leukoc. Biol., July 1, 2003; 74(1): 3 - 15.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. M. Fuhler, A. L. Drayer, and E. Vellenga
Decreased phosphorylation of protein kinase B and extracellular signal-regulated kinase in neutrophils from patients with myelodysplasia
Blood, February 1, 2003; 101(3): 1172 - 1180.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. A. Preston, C. S. Zarella, W. F. Pendergraft III, E. H. Rudolph, J. J. Yang, S. B. Sekura, J. C. Jennette, and R. J. Falk
Novel Effects of Neutrophil-Derived Proteinase 3 and Elastase on the Vascular Endothelium Involve In Vivo Cleavage of NF-{kappa}B and Proapoptotic Changes in JNK, ERK, and p38 MAPK Signaling Pathways
J. Am. Soc. Nephrol., December 1, 2002; 13(12): 2840 - 2849.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Kettritz, M. Choi, W. Butt, M. Rane, S. Rolle, F. C. Luft, and J. B. Klein
Phosphatidylinositol 3-Kinase Controls Antineutrophil Cytoplasmic Antibodies--Induced Respiratory Burst in Human Neutrophils
J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1740 - 1749.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
U. Schonermarck, P. Lamprecht, E. Csernok, and W. L. Gross
Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA
Rheumatology, February 1, 2001; 40(2): 178 - 184.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Hattar, U. Sibelius, A. Bickenbach, E. Csernok, W. Seeger, and F. Grimminger
Subthreshold concentrations of anti-proteinase 3 antibodies (c-ANCA) specifically prime human neutrophils for fMLP-induced leukotriene synthesis and chemotaxis
J. Leukoc. Biol., January 1, 2001; 69(1): 89 - 97.
[Abstract] [Full Text]


Home page
J. Am. Soc. Nephrol.Home page
R. KETTRITZ, A. SCHREIBER, F. C. LUFT, and H. HALLER
Role of Mitogen-Activated Protein Kinases in Activation of Human Neutrophils by Antineutrophil Cytoplasmic Antibodies
J. Am. Soc. Nephrol., January 1, 2001; 12(1): 37 - 46.
[Abstract] [Full Text]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP